ProteoGenix - Relationships

Oregon Health & Science University

Oregon Health & Science University (http://www.ohsu.edu) is a national leader in medical research and is in the top 2% of grant-receiving institutions nationwide. Researchers at OHSU and Doernbecher Children's Hospital have made significant advances in the application of genomics and proteomics technologies to the identification of practical diagnostic markers and promising therapeutic targets in order to develop improved treatments for adult and pediatric disease. Under the direction of Dr. Sri Nagalla, the Center for Biomarker Discovery was established in 2001. This center is dedicated to translational functional genomics and proteomics research. In 2002, Proteogenix entered into a sponsored research agreement with OHSU to perform research within the Pediatric Research Laboratory area of the Hatfield Research Center building. The Proteogenix laboratories are located adjacent to the Center for Biomarker Discovery.

© Copyright 2005-2007. All rights reserved.

Proteogenix

Careers at ProteoGenix Director, Human Resources Director, Immunodiagnostics Product Development Research Associate, Immunodiagnostics Product Development

Management Board of Directors Research Staff

Intra-amniotic Infection Pre-term Birth Down Syndrome

Oregon Health & Science University Beckman Coulter Eli Lilly

Genomics Proteomics Metabolomics Bioinformatics

ProteoGenix Publishes Four Landmark Articles on Diagnostic Applications for Pregnancy (Journal of Proteome Research, April 2007) ProteoGenix Receives Best Clinical Study Award at SMFM Annual Meeting for Preterm Birth and Intra-amniotic Infection (February 2007) ProteoGenix Publishes Identification of Novel Biomarkers in Cervical-Vaginal Fluid for Noninvasive Detection of Intra-amniotic Infection (Journal of Proteome Research, January 2007) Test May Prevent Premature Births (BBC, July 2004) Discovery Could Help Prevent Premature Births (CNN and Associated Press, July 2004) Protein Linked to Premature Births (MSNBC and Associated Press, July 2004) OHSU test targets premature births: Scientists are developing a simple blood screening that could cut the number of risky early births nearly in half. (The Oregonian, July 2004) ProteoGenix Publishes Key Study of Intra-amniotic Infection (Journal of the American Medical Association, July 2004) ProteoGenix Scientists Describe Novel Mass Spec Algorithm (Analytical Chemistry, July 2004) ProteoGenix Receives NIH SBIR Award for "Diagnositic proteiomic profiles for aneuploidy" November 2003

Investor Information Contact Information